Mitochondrial NAD + is utilized in essential reactions such as TCA, fatty acid oxidation, and Oxphos 4
Brighten breaks down how perimenopause and menopause shift insulin sensitivity, fat distribution, appetite, and recovery and where glucagon-like peptide-1 (GLP-1) receptor agonists (think semaglutide/Ozempic, Wegovy, liraglutide, tirzepatide as a related incretin therapy) can fit safely alongside hormone therapy, lifting, protein, and smart lab work
Ultimately, this can lead to the development of new theories and paradigms that carry science forward
The drug doseresponse with respect to side effects, safety, and efficacy for the treatment of obesity are not much known
L- 30-60